Related Experiment Video

Updated: Aug 19, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Neuropsychological effects of exposure to anticonvulsant medication in utero

J Vinten1, N Adab, U Kini

  • 1University Department of Neurosciences, Liverpool,UK.

Neurology
|March 23, 2005
PubMed

Insights

In utero exposure to sodium valproate may harm cognitive development in children. This antiepileptic drug is linked to lower verbal IQ and memory issues in school-aged children.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pharmacology

Background:

  • Antiepileptic drugs (AEDs) are commonly prescribed to manage epilepsy during pregnancy.
  • Understanding the long-term cognitive effects of prenatal AED exposure is crucial for patient counseling and management.
  • Differential drug effects on neurodevelopment require further investigation.

Purpose of the Study:

  • To investigate the long-term differential drug effects of in utero antiepileptic drug (AED) exposure on cognitive functioning in school-aged children.
  • To compare cognitive outcomes in children exposed to various AEDs versus those not exposed.
  • To identify specific AEDs associated with potential neurodevelopmental risks.

Main Methods:

  • Recruitment of mothers with epilepsy and their children from specialist clinics.
  • Application of a comprehensive battery of neuropsychological tests to mother-child pairs.
  • Retrospective analysis of cognitive profiles in relation to prenatal AED exposure.

Main Results:

  • 249 children aged 6-16 underwent neuropsychological assessment.
  • Children exposed to sodium valproate in utero showed significantly lower verbal IQ compared to other groups.
  • Sodium valproate exposure was associated with increased likelihood of IQ below 69 and memory impairment.
  • Maternal IQ, sodium valproate exposure, and seizure frequency predicted verbal IQ.

Conclusions:

  • In utero exposure to sodium valproate may have detrimental effects on neuropsychological development.
  • This study highlights the potential risks associated with sodium valproate during pregnancy.
  • Further research is warranted to explore mechanisms and long-term outcomes.
Abstract

More Related Videos

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...